← Back to patent-cliff list

CAS 771-99-3

4-Phenylpiperidine4-phenylpiperidine

Codes: (XX)859946-1-b, (V)663167-2-a, ADX-71149-006

Application context (from source-drug indications)

Biliary tract cancerTasurgratinibBile duct cancerTasurgratinibSolid tumourTasurgratinibCholangiocarcinomaTasurgratinibBreast cancerTasurgratinibHepatic function declineTasurgratinibSeizureADX-71149Major depressive disorderADX-71149SchizophreniaADX-71149意识错乱ADX-71149知觉障碍ADX-71149

Source drugs (routes using this intermediate)

DrugTierExpiry
TasurgratinibTier C — Watch / trade-
ADX-71149Tier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.